Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Vaccines

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 223 articles:
HTML format
Text format



Single Articles


    August 2019
  1. LINDSEY BB, Hoschler K, de Silva TI
    Complexities in predicting the immunogenicity of live attenuated influenza vaccines.
    Clin Infect Dis. 2019 Aug 14. pii: 5549953. doi: 10.1093.
    PubMed     Text format    


  2. MONTO AS
    Effectiveness of the live attenuated influenza vaccine: was additional of the second type B lineage a step too far?
    Clin Infect Dis. 2019 Aug 13. pii: 5549602. doi: 10.1093.
    PubMed     Text format    


  3. WEINBERGER DM, Shapiro ED
    Pneumococcal Vaccines for Adults: What's Next?
    Clin Infect Dis. 2019 Aug 12. pii: 5546063. doi: 10.1093.
    PubMed     Text format    


  4. AHMED SS, Pondo T, Xing W, McGee L, et al
    Early Impact of 13-valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease among Adults with and without Underlying Medical Conditions-United States.
    Clin Infect Dis. 2019 Aug 12. pii: 5546062. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. GOUMA S, Weirick M, Hensley SE
    Potential antigenic mismatch of the H3N2 component of the 2019 Southern Hemisphere influenza vaccine.
    Clin Infect Dis. 2019 Aug 11. pii: 5546015. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. LEROUX-ROELS G, Bebia Z, Maes C, Aerssens A, et al
    Safety and immunogenicity of a second dose of an investigational maternal trivalent Group B streptococcus vaccine in non-pregnant women 4-6 years after a first dose: results from a phase 2 trial.
    Clin Infect Dis. 2019 Aug 8. pii: 5545276. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. MEDER KN, Jayasinghe S, Beard F, Dey A, et al
    Long-term impact of pneumococcal conjugate vaccines on invasive disease and pneumonia hospitalisations in Indigenous and non-Indigenous Australians.
    Clin Infect Dis. 2019 Aug 7. pii: 5544590. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. WIESE AD, Grijalva CG
    To boost or not to boost? Lessons from the Australian pneumococcal conjugate vaccination program.
    Clin Infect Dis. 2019 Aug 7. pii: 5544622. doi: 10.1093.
    PubMed     Text format    


    July 2019
  9. RAY GT, Lewis N, Klein NP, Daley MF, et al
    Depletion of Susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine Effectiveness.
    Clin Infect Dis. 2019 Jul 28. pii: 5540005. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. HUGHES MM, Reed C, Flannery B, Garg S, et al
    Projected Population Benefit of Increased Effectiveness and Coverage of Influenza Vaccination on Influenza Burden - United States.
    Clin Infect Dis. 2019 Jul 25. pii: 5538868. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. CICCONI P, Jones C, Sarkar E, Reyes LS, et al
    First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults.
    Clin Infect Dis. 2019 Jul 24. pii: 5537685. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. KORSTEN K, Bont LJ
    Sustained cellular and humoral immune responses from an adenoviral vector-based RSV vaccine.
    Clin Infect Dis. 2019 Jul 24. pii: 5537713. doi: 10.1093.
    PubMed     Text format    


  13. KHAGAYI S, Omore R, Otieno GP, Ogwel B, et al
    Effectiveness of monovalent rotavirus vaccine against hospitalization with acute rotavirus gastroenteritis in Kenyan children.
    Clin Infect Dis. 2019 Jul 20. pii: 5536640. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. OEHLER RL
    On Measles, Vaccination, Social Media Activism and How to Win Back Our Role as our Patients' Best Advocates.
    Clin Infect Dis. 2019 Jul 15. pii: 5532609. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. MISCHLINGER J, Muranaka R, Buhler S, Ramharter M, et al
    Measles, vaccines and types of perception bias in public debates.
    Clin Infect Dis. 2019 Jul 12. pii: 5531659. doi: 10.1093.
    PubMed     Text format    


    June 2019
  16. FERDINANDS JM, Alyanak E, Reed C, Fry AM, et al
    Waning of influenza vaccine protection: Exploring the trade-offs of changes in vaccination timing among older adults.
    Clin Infect Dis. 2019 Jun 29. pii: 5525379. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. KLEIN NP, Fireman B
    If Influenza Vaccines Wane Can We Delay Vaccination Without Compromising Coverage?
    Clin Infect Dis. 2019 Jun 29. pii: 5525380. doi: 10.1093.
    PubMed     Text format    


  18. YAN D, Wang D, Zhu S, Zhang Y, et al
    Immunogenicity of oral polio vaccine and Salk inactive polio vaccine against Xinjiang imported type 1 wild poliovirus.
    Clin Infect Dis. 2019 Jun 25. pii: 5523198. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. BLYTH CC, Jayasinghe S, Andrews RM
    A rationale for change: an increase in Invasive Pneumococcal Disease in fully vaccinated children.
    Clin Infect Dis. 2019 Jun 18. pii: 5519836. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. GROENEVELD GH, Wijn DH, Vollaard AM
    Immune related adverse events in cancer patients receiving influenza vaccination and immune checkpoint inhibitors.
    Clin Infect Dis. 2019 Jun 17. pii: 5519876. doi: 10.1093.
    PubMed     Text format    


  21. TURNER P, Leab P, Ly S, Sao S, et al
    Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonisation and Invasive Disease in Cambodian Children.
    Clin Infect Dis. 2019 Jun 7. pii: 5512979. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. MURDOCH DR
    Assessing the Impact of Pneumococcal Conjugate Vaccines.
    Clin Infect Dis. 2019 Jun 7. pii: 5512963. doi: 10.1093.
    PubMed     Text format    


  23. LIN KY, Sun HY, Chen YH, Lo YC, et al
    Effect of a hepatitis A vaccination campaign during a hepatitis A outbreak in Taiwan, 2015-2017: a modeling study.
    Clin Infect Dis. 2019 Jun 3. pii: 5510337. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2019
  24. GROOME MJ, Tate JE, Arnold M, Chitnis M, et al
    Evaluation of intussusception after oral monovalent rotavirus vaccination in South Africa.
    Clin Infect Dis. 2019 May 24. pii: 5498228. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. KITCHIN N, Remich SA, Peterson J, Peng Y, et al
    A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
    Clin Infect Dis. 2019 May 24. pii: 5498282. doi: 10.1093.
    PubMed     Text format     Abstract available



  26. Preliminary Assessment of the Efficacy of a T-Cell-Based Influenza Vaccine, MVA-NP+M1, in Humans.
    Clin Infect Dis. 2019 May 23. pii: 5497806. doi: 10.1093.
    PubMed     Text format    


  27. MONTO AS, Petrie JG
    Improving influenza vaccine effectiveness: ways to begin solving the problem.
    Clin Infect Dis. 2019 May 17. pii: 5491466. doi: 10.1093.
    PubMed     Text format    


  28. BELONGIA EA, McLean HQ
    Influenza Vaccine Effectiveness: Defining the H3N2 Problem.
    Clin Infect Dis. 2019 May 17. pii: 5491465. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. CHAGUZA C, Heinsbroek E, Gladstone RA, Tafatatha T, et al
    Early signals of vaccine driven perturbation seen in pneumococcal carriage population genomic data.
    Clin Infect Dis. 2019 May 16. pii: 5490137. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. JALLOW S, Wilmshurst JM, Howard W, Copelyn J, et al
    Accelerated immunodeficiency-associated vaccine derived poliovirus serotype 3 (iVDPV3) sequence evolution rate in a 3-month old boy with X-linked agammaglobulinemia and perinatal HIV exposure.
    Clin Infect Dis. 2019 May 14. pii: 5489041. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. CARVALHO CFA, Andrews N, Dabrera G, Ribeiro S, et al
    National Outbreak of Pertussis in England, 2011-2012: A Case-control Study Comparing 3-Component and 5-Component Acellular Vaccines With Whole-cell Pertussis Vaccines.
    Clin Infect Dis. 2019 May 6. pii: 5486166. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. SKOWRONSKI DM, De Serres G
    Evidence in a cluster randomized controlled trial of increased 2009 pandemic risk associated with 2008-09 seasonal influenza vaccine receipt.
    Clin Infect Dis. 2019 May 6. pii: 5485848. doi: 10.1093.
    PubMed     Text format    


  33. MATRAJT L, Halloran ME, Antia R
    Successes and failures of the live-attenuated influenza vaccine: can we do better?
    Clin Infect Dis. 2019 May 6. pii: 5485903. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2019
  34. WOLFSON LJ, Daniels VJ, Altland A, Black W, et al
    The Impact of Varicella Vaccination on the Incidence of Varicella and Herpes Zoster in the United States: Updated Evidence From Observational Databases, 1991-2016.
    Clin Infect Dis. 2019 Apr 24. pii: 5477436. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. KOBAYASHI M, Bigogo G, Kim L, Mogeni OD, et al
    Impact of 10-valent Pneumococcal Conjugate Vaccine Introduction on Pneumococcal Carriage and Antibiotic Susceptibility Patterns among Children aged <5 Years and Adults with HIV Infection, Kenya 2009-2013.
    Clin Infect Dis. 2019 Apr 9. pii: 5432315. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. LINDHOLM DA, Fisher RD, Montgomery JR, Davidson W, et al
    Preemptive Tecovirimat Use in an Active Duty Member Presenting with Acute Myeloid Leukemia after Smallpox Vaccination.
    Clin Infect Dis. 2019 Apr 9. pii: 5432316. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. STEENS A, Winje BA, White RA, Odsbu I, et al
    Indirect Effects of Pneumococcal Childhood Vaccination in Individuals Treated With Immunosuppressive Drugs in Ambulatory Care: A Case-cohort Study.
    Clin Infect Dis. 2019;68:1367-1373.
    PubMed     Text format     Abstract available


  38. KELLNER JD
    Who Benefits, and How Much? Indirect Effects of Childhood Pneumococcal Vaccination in Adults at Increased Risk of Pneumococcal Disease.
    Clin Infect Dis. 2019;68:1374-1375.
    PubMed     Text format    


  39. MEMOLI MJ, Han A, Walters KA, Czajkowski L, et al
    Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development.
    Clin Infect Dis. 2019 Apr 6. pii: 5429562. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. HARRIMAN K, Healy CM
    How Important Is the Type of Acellular Pertussis Vaccine?
    Clin Infect Dis. 2019 Apr 5. pii: 5486164. doi: 10.1093.
    PubMed     Text format    


    March 2019
  41. LE ROUX DM, Nicol MP, Myer L, Vanker A, et al
    Lower Respiratory Tract Infections in Children in a Well-vaccinated South African Birth Cohort: Spectrum of Disease and Risk Factors.
    Clin Infect Dis. 2019 Mar 29. pii: 5423418. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. LU CY, Chiang CS, Chiu CH, Wang ET, et al
    Successful Control of Streptococcus pneumoniae 19A Replacement With a Catch-up Primary Vaccination Program in Taiwan.
    Clin Infect Dis. 2019 Mar 28. pii: 5421736. doi: 10.1093/cid/ciy1127.
    PubMed     Text format     Abstract available


  43. BLOK BA, de Bree LCJ, Diavatopoulos DA, Langereis JD, et al
    INTERACTING NON-SPECIFIC IMMUNOLOGICAL EFFECTS OF BCG AND Tdapf VACCINATIONS: AN EXPLORATIVE RANDOMIZED TRIAL.
    Clin Infect Dis. 2019 Mar 28. pii: 5421296. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. VAN AALST M, Garrido HMG, van der Leun J, Meek B, et al
    Immunogenicity of the currently recommended pneumococcal vaccination schedule in patients with inflammatory bowel disease.
    Clin Infect Dis. 2019 Mar 22. pii: 5418537. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. VERDOODT F, Dehlendorff C, Kjaer SK
    Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: A Danish nationwide cohort study.
    Clin Infect Dis. 2019 Mar 20. pii: 5403490. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. ROMANIN V, Acosta AM, Juarez MDV, Briere E, et al
    Maternal Vaccination in Argentina: Tdap Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants Less Than 2 Months of Age.
    Clin Infect Dis. 2019 Mar 16. pii: 5381906. doi: 10.1093.
    PubMed     Text format     Abstract available


  47. CHONG CR, Park VJ, Cohen B, Postow MA, et al
    Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors (ICI).
    Clin Infect Dis. 2019 Mar 15. pii: 5381697. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. LEVY C, Varon E, Ouldali N, Bechet S, et al
    Changes in invasive pneumococcal disease spectrum after 13 valent pneumococcal conjugate vaccine implementation.
    Clin Infect Dis. 2019 Mar 14. pii: 5380638. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. COLIN-JONES R, Shakya M, Voysey M, Theiss-Nyland K, et al
    Logistics of Implementing a Large-scale Typhoid Vaccine Trial in Kathmandu, Nepal.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  50. LUTHRA K, Watts E, Debellut F, Pecenka C, et al
    A Review of the Economic Evidence of Typhoid Fever and Typhoid Vaccines.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  51. THEISS-NYLAND K, Qadri F, Colin-Jones R, Zaman K, et al
    Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  52. LAURENS MB, Sirima SB, Rotrosen ET, Siribie M, et al
    A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  53. THEISS-NYLAND K, Shakya M, Colin-Jones R, Voysey M, et al
    Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  54. JAMKA LP, Simiyu KW, Bentsi-Enchill AD, Mwisongo AJ, et al
    Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  55. LIU X, Pitzer VE, Pollard AJ, Voysey M, et al
    The Design and Analysis of Seroefficacy Studies for Typhoid Conjugate Vaccines.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  56. SAHA S, Islam MS, Sajib MSI, Saha S, et al
    Epidemiology of Typhoid and Paratyphoid: Implications for Vaccine Policy.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  57. KAUFHOLD S, Yaesoubi R, Pitzer VE
    Predicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  58. MEIRING JE, Sambakunsi R, Moyo E, Misiri T, et al
    Community Engagement Before Initiation of Typhoid Conjugate Vaccine Trial in Schools in Two Urban Townships in Blantyre, Malawi: Experience and Lessons.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  59. DEBELLUT F, Hendrix N, Pitzer VE, Neuzil KM, et al
    Forecasting Demand for the Typhoid Conjugate Vaccine in Low- and Middle-income Countries.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  60. MEIRING JE, Laurens MB, Patel P, Patel P, et al
    Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  61. VINK P, Ramon Torrell JM, Sanchez Fructuoso A, Kim SJ, et al
    Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: a Phase III, Randomized Clinical Trial.
    Clin Infect Dis. 2019 Mar 7. pii: 5370445. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. MILLER G
    Vaccine Prevention of Herpes Zoster in Organ Transplant Recipients: A Busy Intersection of Immune Responses to Foreign Antigens.
    Clin Infect Dis. 2019 Mar 7. pii: 5370442. doi: 10.1093.
    PubMed     Text format    


  63. HANSSON K, Rosdahl A, Insulander M, Vene S, et al
    Tick-borne encephalitis (TBE) vaccine failures: A ten-year retrospective study supporting the rationale for adding an extra priming dose in individuals from the age of 50 years.
    Clin Infect Dis. 2019 Mar 7. pii: 5370446. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2019
  64. MOSCICKI AB, Karalius B, Tassiopoulos K, Yao TJ, et al
    Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth.
    Clin Infect Dis. 2019 Feb 21. pii: 5423927. doi: 10.1093/cid/ciy1040.
    PubMed     Text format     Abstract available


  65. HEFELE L, Syphan S, Xayavong D, Homsana A, et al
    Seroprotection at different levels of the health care system after routine vaccination with DTPw-HepB-Hib in Lao PDR.
    Clin Infect Dis. 2019 Feb 19. pii: 5335760. doi: 10.1093.
    PubMed     Text format     Abstract available


  66. CHURCH JA, Rukobo S, Govha M, Lee B, et al
    The impact of improved water, sanitation and hygiene on oral rotavirus vaccine immunogenicity in Zimbabwean infants: sub-study of a cluster-randomized trial.
    Clin Infect Dis. 2019 Feb 16. pii: 5321771. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. WIESE AD, Huang X, Yu C, Mitchel EF, et al
    Changes in otitis media episodes and pressure equalization tube insertions among young children following introduction of the 13-valent pneumococcal conjugate vaccine: A birth-cohort based study.
    Clin Infect Dis. 2019 Feb 16. pii: 5321113. doi: 10.1093.
    PubMed     Text format     Abstract available


  68. BIGOGO GM, Audi A, Auko J, Aol GO, et al
    Indirect Effects of 10-Valent Pneumococcal Conjugate Vaccine Against Adult Pneumococcal Pneumonia in Rural Western Kenya.
    Clin Infect Dis. 2019 Feb 16. pii: 5346100. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. NEUZIL KM, Pollard AJ, Marfin AA
    Introduction of Typhoid Conjugate Vaccines in Africa and Asia.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  70. KARIUKI S, Mbae C, Onsare R, Kavai SM, et al
    Multidrug-resistant Nontyphoidal Salmonella Hotspots as Targets for Vaccine Use in Management of Infections in Endemic Settings.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  71. YOUSAFZAI MT, Qamar FN, Shakoor S, Saleem K, et al
    Ceftriaxone-resistant Salmonella Typhi Outbreak in Hyderabad City of Sindh, Pakistan: High Time for the Introduction of Typhoid Conjugate Vaccine.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  72. SAHASTRABUDDHE S, Saluja T
    Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  73. BENTSI-ENCHILL AD, Hombach J
    Revised Global Typhoid Vaccination Policy.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  74. STEELE AD, Parashar UD
    Rotavirus Vaccines set to make inroads in Asia.
    Clin Infect Dis. 2019 Feb 13. pii: 5316811. doi: 10.1093.
    PubMed     Text format    


  75. SCHWARTZ LM, Zaman K, Yunus M, Basunia AH, et al
    Impact of rotavirus vaccine introduction in children less than 2 years of age presenting for medical care with diarrhea in rural Matlab, Bangladesh.
    Clin Infect Dis. 2019 Feb 12. pii: 5316286. doi: 10.1093.
    PubMed     Text format     Abstract available


  76. DESTEFANO F, Bodenstab HM, Offit PA
    Principal Controversies in Vaccine Safety in the United States.
    Clin Infect Dis. 2019 Feb 12. pii: 5316263. doi: 10.1093.
    PubMed     Text format     Abstract available


  77. SEGALOFF HE, Leventer-Roberts M, Riesel D, Malosh RE, et al
    Influenza Vaccine Effectiveness Against Hospitalization in Fully and Partially Vaccinated Children in Israel; 2015-16, 2016-17, and 2017-18.
    Clin Infect Dis. 2019 Feb 11. pii: 5314854. doi: 10.1093.
    PubMed     Text format     Abstract available


  78. SKOWRONSKI DM, De Serres G, Orenstein WA
    Caution required in the use of administrative data and general laboratory submissions for influenza vaccine effectiveness estimation.
    Clin Infect Dis. 2019 Feb 7. pii: 5308623. doi: 10.1093.
    PubMed     Text format    


  79. ROLFES MA, Flannery B, Chung J, O'Halloran A, et al
    Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season.
    Clin Infect Dis. 2019 Feb 2. pii: 5305915. doi: 10.1093.
    PubMed     Text format     Abstract available


  80. NEUZIL KM, Fitzpatrick MC
    The Impact of Influenza Vaccine: It's the Size of the Glass.
    Clin Infect Dis. 2019 Feb 2. pii: 5306034. doi: 10.1093.
    PubMed     Text format    


  81. KOREM M, Orenbuch-Harroch E, Ben-Chetrit E, Israel S, et al
    Intensive care admissions and associated severity of influenza B versus A during influenza B-vaccine mismatched seasons.
    Clin Infect Dis. 2019 Feb 1. pii: 5305596. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2019
  82. HASSO-AGOPSOWICZ M, Ladva CN, Lopman B, Sanderson C, et al
    Global review of the age distribution of rotavirus disease in children aged <5 years before the introduction of rotavirus vaccination.
    Clin Infect Dis. 2019 Jan 28. pii: 5303786. doi: 10.1093.
    PubMed     Text format     Abstract available


  83. DIALLO A, Diop OM, Diop D, Niang MN, et al
    Effectiveness of seasonal influenza vaccination of children in Senegal during a year of vaccine mismatch: a cluster-randomized trial.
    Clin Infect Dis. 2019 Jan 28. pii: 5303780. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. GREENWOOD B
    Sustaining Protection Against Epidemic Meningitis in Africa After Vaccination.
    Clin Infect Dis. 2019;68:444-445.
    PubMed     Text format    


  85. MORDMULLER B, Sulyok M, Egger-Adam D, Resende M, et al
    First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria.
    Clin Infect Dis. 2019 Jan 10. pii: 5281109. doi: 10.1093/cid/ciy1140.
    PubMed     Text format     Abstract available


  86. VEKEMANS J, Gouvea-Reis F, Kim JH, Excler JL, et al
    The path to group A Streptococcus vaccines: WHO research and development technology roadmap and preferred product characteristics.
    Clin Infect Dis. 2019 Jan 8. pii: 5280612. doi: 10.1093/cid/ciy1143.
    PubMed     Text format     Abstract available


  87. ASNER SA, Agyeman PKA, Gradoux E, Posfay-Barbe KM, et al
    Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines - a prospective population-based cohort study.
    Clin Infect Dis. 2019 Jan 2. pii: 5270128. doi: 10.1093/cid/ciy1139.
    PubMed     Text format     Abstract available


    December 2018
  88. HARDER T, Siedler A
    Systematic review and meta-analysis of chickenpox vaccination and risk of herpes zoster: a quantitative view on the "exogenous boosting hypothesis".
    Clin Infect Dis. 2018 Dec 24. pii: 5258112. doi: 10.1093/cid/ciy1099.
    PubMed     Text format     Abstract available


  89. MUJURU HA, Burnett E, Nathoo KJ, Ticklay I, et al
    Monovalent rotavirus vaccine effectiveness against rotavirus hospitalizations among children in Zimbabwe.
    Clin Infect Dis. 2018 Dec 23. pii: 5258061. doi: 10.1093/cid/ciy1096.
    PubMed     Text format     Abstract available


  90. MEHANNA H, Bryant TS, Babrah J, Louie K, et al
    Human papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV16 prevalence in the UK; a cross-sectional study.
    Clin Infect Dis. 2018 Dec 22. pii: 5257796. doi: 10.1093/cid/ciy1081.
    PubMed     Text format     Abstract available


  91. SOENTJENS P, De Koninck K, Tsoumanis A, Herssens N, et al
    A Comparative Immunogenicity and Safety Trial of Two Different Schedules of Single-visit Intradermal Rabies Post-exposure Vaccination Following a Single-visit Pre-exposure Vaccination.
    Clin Infect Dis. 2018 Dec 19. pii: 5253211. doi: 10.1093.
    PubMed     Text format     Abstract available


  92. DEJON-AGOBE JC, Ateba-Ngoa U, Lalremruata A, Homoet A, et al
    Controlled human malaria infection of healthy lifelong malaria-exposed adults to assess safety, immunogenicity and efficacy of the asexual blood stage malaria vaccine candidate GMZ2.
    Clin Infect Dis. 2018 Dec 18. pii: 5252072. doi: 10.1093/cid/ciy1087.
    PubMed     Text format     Abstract available


  93. POLLOCK L, Bennett A, Jere KC, Dube Q, et al
    Non-secretor histo-blood group antigen phenotype is associated with reduced risk of clinical rotavirus vaccine failure in Malawian infants.
    Clin Infect Dis. 2018 Dec 18. pii: 5252030. doi: 10.1093/cid/ciy1067.
    PubMed     Text format     Abstract available


  94. FERDINANDS JM, Patel MM, Foppa IM, Fry AM, et al
    Influenza Vaccine Effectiveness.
    Clin Infect Dis. 2018 Dec 18. pii: 5251717. doi: 10.1093/cid/ciy1084.
    PubMed     Text format    


  95. CHEN H, Alvarez JJS, Ng SH, Nielsen R, et al
    Passage adaptation correlates with the reduced efficacy of the influenza vaccine.
    Clin Infect Dis. 2018 Dec 18. pii: 5252062. doi: 10.1093/cid/ciy1065.
    PubMed     Text format     Abstract available


  96. SEMCHENKO EA, Tan A, Borrow R, Seib KL, et al
    The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae.
    Clin Infect Dis. 2018 Dec 14. pii: 5247042. doi: 10.1093/cid/ciy1061.
    PubMed     Text format     Abstract available


  97. NICHOLS MK, Andrew MK, Ye L, Hatchette TF, et al
    The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness (VE) to Prevent Influenza-Related Hospitalizations over Four Influenza Seasons in Canada.
    Clin Infect Dis. 2018 Dec 3. pii: 5228721. doi: 10.1093/cid/ciy1009.
    PubMed     Text format     Abstract available


    November 2018
  98. HARPAZ R, Leung JW
    The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Children.
    Clin Infect Dis. 2018 Nov 29. pii: 5213086. doi: 10.1093.
    PubMed     Text format     Abstract available


  99. HARPAZ R, Leung JW
    The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Older Adults.
    Clin Infect Dis. 2018 Nov 29. pii: 5213085. doi: 10.1093.
    PubMed     Text format     Abstract available


  100. BRICKLEY EB, Wright PF, Khalenkov A, Neuzil KM, et al
    The effect of pre-existing immunity on virus detection and immune responses in a phase II randomized trial of a Russian-backbone live attenuated influenza vaccine in Bangladeshi children.
    Clin Infect Dis. 2018 Nov 27. pii: 5210472. doi: 10.1093/cid/ciy1004.
    PubMed     Text format     Abstract available


  101. LEWIS KDC, Ortiz JR, Rahman MZ, Levine MZ, et al
    Immunogenicity and viral shedding of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled trial among pre-school aged children in urban Bangladesh.
    Clin Infect Dis. 2018 Nov 27. pii: 5210460. doi: 10.1093/cid/ciy1003.
    PubMed     Text format     Abstract available


  102. MCHUGH L, Marshall HS, Perrett KP, Nolan T, et al
    The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study.
    Clin Infect Dis. 2018 Nov 23. pii: 5202330. doi: 10.1093.
    PubMed     Text format     Abstract available


  103. KOLDITZ M, Schmitt J, Pletz MW, Tesch F, et al
    Impact of the 13-valent pneumococcal conjugate vaccine on incidence of all-cause pneumonia in adults aged >/= 60 years - a population-based retrospective cohort study.
    Clin Infect Dis. 2018 Nov 21. pii: 5194155. doi: 10.1093.
    PubMed     Text format     Abstract available


  104. LOEVINSOHN G, Rosman L, Moss WJ
    Measles Seroprevalence and Vaccine Responses in HIV-Infected Adolescents and Adults: A Systematic Review.
    Clin Infect Dis. 2018 Nov 17. pii: 5188002. doi: 10.1093.
    PubMed     Text format     Abstract available


  105. MUTSAERTS EAML, Nunes MC, van Rijswijk MN, Klipstein-Grobusch K, et al
    Measles immunity at 4.5 years of age following vaccination at 9 and 15-18 months of age among HIV-infected, HIV-exposed-uninfected and HIV-unexposed children.
    Clin Infect Dis. 2018 Nov 12. pii: 5174340. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2018
  106. ALTAMIRANO J, Purington N, Behl R, Sarnquist C, et al
    Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  107. GAENSBAUER JT, Gast C, Bandyopadhyay AS, O'Ryan M, et al
    Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  108. ALTAMIRANO J, Leary S, van Hoorebeke C, Sarnquist C, et al
    Validation of a High-throughput, Multiplex, Real-time Qualitative Polymerase Chain Reaction Assay for the Detection of Sabin Oral Polio Vaccine in Environmental Samples.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  109. VAN HOOREBEKE C, Huang C, Leary S, Holubar M, et al
    Lab Protocol Paper: Use of a High-throughput, Multiplex Reverse-transcription Quantitative Polymerase Chain Reaction Assay for Detection of Sabin Oral Polio Vaccine in Fecal Samples.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  110. BHAUMIK SK, Kulkarni RR, Weldon WC, Silveira ELV, et al
    Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models: Support for at least 2 Doses.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  111. JARVIS CI, Altamirano J, Sarnquist C, Edmunds WJ, et al
    Spatial Analyses of Oral Polio Vaccine Transmission in an Community Vaccinated With Inactivated Polio Vaccine.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  112. RESIK S, Tejeda A, Mach O, Fonseca M, et al
    Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  113. FU R, Altamirano J, Sarnquist CC, Maldonado YA, et al
    Assessing the Risk of Vaccine-derived Outbreaks After Reintroduction of Oral Poliovirus Vaccine in Postcessation Settings.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  114. BRICKLEY EB, Wieland-Alter W, Connor RI, Ackerman ME, et al
    Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine-only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chil
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  115. ALTAMIRANO J, Sarnquist C, Behl R, Garcia-Garcia L, et al
    OPV Vaccination and Shedding Patterns in Mexican and US Children.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  116. SARNQUIST C, Holubar M, Garcia-Garcia L, Ferreyra-Reyes L, et al
    Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  117. HALPERN MS, Altamirano J, Maldonado Y
    Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  118. BANDYOPADHYAY AS, Modlin JF, Wenger J, Gast C, et al
    Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  119. DANINO D, Givon-Lavi N, Ben-Shimol S, Greenberg D, et al
    Understanding the evolution of antibiotic-nonsusceptible pneumococcal nasopharyngeal colonization following pneumococcal conjugate vaccines implementation in young children.
    Clin Infect Dis. 2018 Oct 29. pii: 5146358. doi: 10.1093.
    PubMed     Text format     Abstract available


  120. HAVERS FP, Chung JR, Belongia EA, McLean HQ, et al
    Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017.
    Clin Infect Dis. 2018 Oct 27. pii: 5145968. doi: 10.1093.
    PubMed     Text format     Abstract available


  121. SINGS HL, De Wals P, Gessner BD, Isturiz R, et al
    Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-Analysis of Observational Studies.
    Clin Infect Dis. 2018 Oct 23. pii: 5142858. doi: 10.1093.
    PubMed     Text format     Abstract available


  122. LOPEZ BERNAL JA, Andrews N, Amirthalingam G
    The use of quasi-experimental designs for vaccine evaluation.
    Clin Infect Dis. 2018 Oct 22. pii: 5140188. doi: 10.1093.
    PubMed     Text format     Abstract available


  123. PRAHARAJ I, Platts-Mills JA, Taneja S, Antony K, et al
    Diarrheal etiology and impact of co-infections on rotavirus vaccine efficacy estimates in a clinical trial of a monovalent human-bovine (116E) oral rotavirus vaccine, Rotavac, India.
    Clin Infect Dis. 2018 Oct 17. pii: 5134205. doi: 10.1093.
    PubMed     Text format     Abstract available


  124. SMITS G, Stabell Benn C, Whittle H, van Binnendijk R, et al
    Maternal measles antibodies and their influence on all-cause mortality following measles vaccination: an alternative to measure very low maternal antibody levels.
    Clin Infect Dis. 2018 Oct 16. pii: 5133427. doi: 10.1093.
    PubMed     Text format     Abstract available


  125. WEINBERGER DM, Shapiro ED
    Prevention of Pneumococcal Infections in Adults using Conjugate Vaccines: No Easy Answers.
    Clin Infect Dis. 2018 Oct 12. pii: 5127383. doi: 10.1093.
    PubMed     Text format    


  126. VADLAMUDI NK, Chen A, Marra F
    Impact of 13-pneumococcal conjugate vaccine among adults: a systematic review and meta-analysis.
    Clin Infect Dis. 2018 Oct 12. pii: 5127380. doi: 10.1093.
    PubMed     Text format     Abstract available


  127. HYLE EP, Fields NF, Fiebelkorn AP, Walker AT, et al
    The Clinical Impact and Cost-effectiveness of MMR Vaccination to Prevent Measles Importations among US International Travelers.
    Clin Infect Dis. 2018 Oct 11. pii: 5127132. doi: 10.1093.
    PubMed     Text format     Abstract available


  128. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Vaccine effectiveness against lineage matched and mismatched influenza B viruses across 8 seasons in Canada, 2010-11 to 2017-18.
    Clin Infect Dis. 2018 Oct 11. pii: 5127119. doi: 10.1093.
    PubMed     Text format     Abstract available


  129. THOMPSON MG, Kwong JC, Regan AK, Katz MA, et al
    Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016.
    Clin Infect Dis. 2018 Oct 11. pii: 5126390. doi: 10.1093.
    PubMed     Text format     Abstract available


  130. MUNOZ FM
    Influenza Vaccination During Pregnancy Can Protect Women Against Hospitalization Across Continents.
    Clin Infect Dis. 2018 Oct 11. pii: 5126392. doi: 10.1093.
    PubMed     Text format    


  131. HILLIER SL, Ferrieri P, Edwards MS, Ewell M, et al
    A Phase II Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide -Tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization with GBS III.
    Clin Infect Dis. 2018 Oct 3. pii: 5114388. doi: 10.1093.
    PubMed     Text format     Abstract available


  132. YOUNG B, Sadarangani S, Sen Yew H, Yung CF, et al
    Six-monthly versus annual influenza vaccination in older adults in the tropics: an observer-blind, active-comparator controlled, randomised superiority trial.
    Clin Infect Dis. 2018 Oct 1. pii: 5113434. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  133. WANG W, Chen Q, Ford-Siltz LA, Katzelnick LC, et al
    Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains after Vaccination with Inactivated Trivalent Influenza Vaccine Vary with Age and Prior Year Vaccination.
    Clin Infect Dis. 2018 Sep 25. pii: 5106972. doi: 10.1093.
    PubMed     Text format     Abstract available


  134. GIBANI MM, Voysey M, Jin C, Jones C, et al
    The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies.
    Clin Infect Dis. 2018 Sep 25. pii: 5106547. doi: 10.1093.
    PubMed     Text format     Abstract available


  135. LEE RU, Phillips CJ, Faix DJ
    Seasonal Influenza Vaccine Impact on Pandemic H1N1 Vaccine Efficacy.
    Clin Infect Dis. 2018 Sep 20. pii: 5104116. doi: 10.1093.
    PubMed     Text format     Abstract available


  136. PINANA JL, Perez A, Montoro J, Gimenez E, et al
    Clinical effectiveness of influenza vaccination after allogeneic hematopoietic stem cell transplantation: A cross-sectional prospective observational study.
    Clin Infect Dis. 2018 Sep 15. pii: 5098399. doi: 10.1093.
    PubMed     Text format     Abstract available


  137. FLANNERY B, Chung JR, Monto AS, Martin ET, et al
    Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season.
    Clin Infect Dis. 2018 Sep 11. pii: 5094815. doi: 10.1093.
    PubMed     Text format     Abstract available


  138. RAY GT, Lewis N, Klein NP, Daley MF, et al
    Intra-season Waning of Influenza Vaccine Effectiveness.
    Clin Infect Dis. 2018 Sep 10. pii: 5094689. doi: 10.1093.
    PubMed     Text format     Abstract available


  139. LIPSITCH M
    Challenges of vaccine effectiveness and waning studies.
    Clin Infect Dis. 2018 Sep 10. pii: 5094713. doi: 10.1093.
    PubMed     Text format    


  140. CHEN LH, Kozarsky PE, Visser LG
    What's old is new again: the re-emergence of yellow fever in Brazil and vaccine shortages.
    Clin Infect Dis. 2018 Sep 10. pii: 5094712. doi: 10.1093.
    PubMed     Text format     Abstract available


  141. COWLING BJ, Lim WW, Perera RAPM, Fang VJ, et al
    Influenza hemagglutination-inhibition antibody titer as a mediator of vaccine-induced protection for influenza B.
    Clin Infect Dis. 2018 Sep 8. pii: 5092748. doi: 10.1093.
    PubMed     Text format     Abstract available


  142. POMAT WS, van den Biggelaar AHJ, Wana S, Greenhill AR, et al
    Safety and immunogenicity of pneumococcal conjugate vaccines in a high-risk population: a randomised controlled trial of 10-valent and 13-valent PCV in Papua New Guinean infants.
    Clin Infect Dis. 2018 Sep 3. pii: 5089945. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2018
  143. USUF E, Bottomley C, Bojang E, Cox I, et al
    Persistence of nasopharyngeal pneumococcal vaccine serotypes and increase of non-vaccine serotypes among vaccinated infants and their mothers five years after PCV13 introduction in The Gambia.
    Clin Infect Dis. 2018 Aug 24. pii: 5079135. doi: 10.1093.
    PubMed     Text format     Abstract available


  144. BLYTH CC, Macartney KK, McRae J, Clark JE, et al
    Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration.
    Clin Infect Dis. 2018 Aug 21. pii: 5077025. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  145. YARO S, Njanpop Lafourcade BM, Ouangraoua S, Ouoba A, et al
    Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?
    Clin Infect Dis. 2018 Jul 26. pii: 5059984. doi: 10.1093.
    PubMed     Text format     Abstract available


  146. BLANCHARD ROHNER G, Chatzis O, Chinwangso P, Rohr M, et al
    Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
    Clin Infect Dis. 2018 Jul 26. pii: 5059783. doi: 10.1093.
    PubMed     Text format     Abstract available


  147. PETOUSIS-HARRIS H, Howe AS, Janine P, Turner N, et al
    Pneumococcal conjugate vaccines turning the tide on inequity - a retrospective cohort study of New Zealand children born 2006-2015.
    Clin Infect Dis. 2018 Jul 19. pii: 5055833. doi: 10.1093.
    PubMed     Text format     Abstract available


  148. BAKER JM, Tate JE, Steiner CA, Haber MJ, et al
    Longer-term direct and indirect effects of infant rotavirus vaccination across all ages in the US; 2000 - 2013: analysis of a large hospital discharge dataset.
    Clin Infect Dis. 2018 Jul 18. pii: 5055445. doi: 10.1093.
    PubMed     Text format     Abstract available


  149. HALPERIN SA, Langley JM, Ye L, MacKinnon-Cameron D, et al
    A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.
    Clin Infect Dis. 2018 Jul 13. pii: 5053576. doi: 10.1093.
    PubMed     Text format     Abstract available


  150. XU Y, Ye J
    Predicting influenza vaccine effectiveness with hemagglutinin sequences is not sufficient enough.
    Clin Infect Dis. 2018 Jul 9. pii: 5050680. doi: 10.1093.
    PubMed     Text format    


  151. MCCLYMONT E, Lee M, Raboud J, Coutlee F, et al
    The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living with HIV.
    Clin Infect Dis. 2018 Jul 7. pii: 5050411. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  152. STEINER-MONARD V, Kamaka K, Karoui O, Roethlisberger S, et al
    The Candidate Blood Stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase I Trial in Exposed and Non Exposed Volunteers.
    Clin Infect Dis. 2018 Jun 26. pii: 5045203. doi: 10.1093.
    PubMed     Text format     Abstract available


  153. SOENTJENS P, Andries P, Aerssens A, Tsoumanis A, et al
    Pre-exposure intradermal rabies vaccination: a non-inferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days.
    Clin Infect Dis. 2018 Jun 25. pii: 5043520. doi: 10.1093.
    PubMed     Text format     Abstract available


  154. TRIEU MC, Jul-Larsen A, Saevik M, Madsen A, et al
    Antibody responses to influenza A/H1N1pdm09 virus after pandemic and seasonal influenza vaccination in healthcare workers: a five-year follow-up study.
    Clin Infect Dis. 2018 Jun 9. pii: 5035295. doi: 10.1093.
    PubMed     Text format     Abstract available


  155. CHERRY JD, Zahn M
    Clinical Characteristics of Measles in Previously Vaccinated and Unvaccinated Patients in California.
    Clin Infect Dis. 2018 Jun 7. pii: 5034094. doi: 10.1093.
    PubMed     Text format     Abstract available


  156. MOSS W
    Measles in Vaccinated Individuals and the Future of Measles Elimination.
    Clin Infect Dis. 2018 Jun 7. pii: 5034071. doi: 10.1093.
    PubMed     Text format    


  157. KILMER GA, Barker LK, Ly KN, Jiles RB, et al
    Hepatitis B vaccination and screening among foreign-born women of reproductive age in the United States: 2013-2015.
    Clin Infect Dis. 2018 Jun 1. pii: 5026244. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  158. SORUP S, Jensen AKG, Aaby P, Benn CS, et al
    Revaccination with Measles-mumps-rubella Vaccine and Infectious Disease Morbidity: A Danish Register-based Cohort Study.
    Clin Infect Dis. 2018 May 26. pii: 5005938. doi: 10.1093.
    PubMed     Text format     Abstract available


  159. MCLAUGHLIN JM, Jiang Q, Isturiz RE, Sings HL, et al
    Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.
    Clin Infect Dis. 2018 May 21. pii: 5000157. doi: 10.1093.
    PubMed     Text format     Abstract available


  160. BURKE RM, Tate JE, Dahl RM, Aliabadi N, et al
    Rotavirus Vaccination Is Associated with Reduced Seizure Hospitalization Risk Among Commercially Insured U.S. Children.
    Clin Infect Dis. 2018 May 16. pii: 4996816. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  161. CASADEVALL A, Pirofski LA
    A Therapeutic Vaccine for Recurrent Vulvovaginal Candidiasis.
    Clin Infect Dis. 2018 Apr 25. pii: 4984538. doi: 10.1093.
    PubMed     Text format    


  162. EDWARDS JE JR, Schwartz MM, Schmidt CS, Sobel JD, et al
    A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial.
    Clin Infect Dis. 2018 Apr 25. pii: 4984537. doi: 10.1093.
    PubMed     Text format     Abstract available


  163. SKOWRONSKI DM, De Serres G
    Role of egg-adaptation mutations in low influenza A(H3N2) vaccine effectiveness during the 2012-13 season.
    Clin Infect Dis. 2018 Apr 24. pii: 4983050. doi: 10.1093.
    PubMed     Text format    


  164. KOSIKOVA M, Li L, Radvak P, Ye Z, et al
    Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications on Seasonal Vaccine Strain Selection and Vaccine Performance.
    Clin Infect Dis. 2018 Apr 17. pii: 4972882. doi: 10.1093.
    PubMed     Text format     Abstract available


  165. BONOMO ME, Deem MW
    Predicting Influenza H3N2 Vaccine Efficacy from Evolution of the Dominant Epitope.
    Clin Infect Dis. 2018 Apr 17. pii: 4972858. doi: 10.1093.
    PubMed     Text format     Abstract available


  166. WILKIN TJ, Chen H, Cespedes MS, Leon-Cruz JT, et al
    A randomized, placebo-controlled trial of the quadrivalent HPV vaccine in HIV-infected adults age 27 years or older: AIDS Clinical Trials Group protocol A5298.
    Clin Infect Dis. 2018 Apr 5. pii: 4961357. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  167. SIGURETHSSON S, Eythorsson E, Hrafnkelsson B, Erlendsdottir H, et al
    Reduction in all-cause acute otitis media in children less than three years of age in primary care following pneumococcal vaccination with PHiD-CV10: A whole population study.
    Clin Infect Dis. 2018 Mar 30. pii: 4956759. doi: 10.1093.
    PubMed     Text format     Abstract available


  168. HANSON KE, Koch B, Bonner K, McRee AL, et al
    National Trends in Parental HPV Vaccination Intentions and Reasons for Hesitancy, 2010-2015.
    Clin Infect Dis. 2018 Mar 27. pii: 4955216. doi: 10.1093.
    PubMed     Text format     Abstract available


  169. BENSON CA, Andersen JW, Macatangay BJC, Mailliard RB, et al
    Safety and Immunogenicity of Zoster Vaccine Live in HIV-Infected Adults with CD4+ Cell Counts Above 200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.
    Clin Infect Dis. 2018 Mar 26. pii: 4953774. doi: 10.1093.
    PubMed     Text format     Abstract available


  170. DE SERRES G, Skowronski DM
    Ecological Fallacy, Nonspecific Outcomes, and the Attribution of Disproportionate Vaccine Benefits.
    Clin Infect Dis. 2018 Mar 21. pii: 4948704. doi: 10.1093.
    PubMed     Text format    


  171. SAITO N, Komori K, Suzuki M, Kishikawa T, et al
    Dose-Dependent Negative Effects of Prior Multiple Vaccinations against Influenza A and Influenza B among School Children: A Study of Kamigoto Island in Japan during the 2011/12, 2012/13 and 2013/14 Influenza Seasons.
    Clin Infect Dis. 2018 Mar 8. pii: 4924693. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  172. COBEY S, Gouma S, Parkhouse K, Chambers BS, et al
    Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012-13.
    Clin Infect Dis. 2018 Feb 20. pii: 4846904. doi: 10.1093.
    PubMed     Text format     Abstract available


  173. ANDERSON EJ, Daugherty MA, Pickering LK, Orenstein WA, et al
    Protecting the Community through Child Vaccination.
    Clin Infect Dis. 2018 Feb 17. pii: 4868144. doi: 10.1093.
    PubMed     Text format     Abstract available


  174. JAYASINGHE S, Chiu C, Quinn H, Menzies R, et al
    Effectiveness of Seven and Thirteen Valent Pneumococcal Conjugate Vaccines in a Schedule without a Booster dose: a Ten Year Observational Study.
    Clin Infect Dis. 2018 Feb 17. pii: 4868133. doi: 10.1093.
    PubMed     Text format     Abstract available



  175. Philippines Says Anti-Dengue Vaccine may be Connected to Three Deaths.
    Clin Infect Dis. 2018 Feb 17. pii: 4868143. doi: 10.1093.
    PubMed     Text format    


  176. WHITNEY CG
    Examining Duration of Protection: should a Booster dose be Part of all Infant Pneumococcal Conjugate Vaccine Programs?
    Clin Infect Dis. 2018 Feb 17. pii: 4868134. doi: 10.1093.
    PubMed     Text format    


  177. KATZ J, Englund JA, Steinhoff MC, Khatry SK, et al
    Impact of timing of influenza vaccination in pregnancy on transplacental antibody transfer, influenza incidence and birth outcomes; a randomized trial in rural Nepal.
    Clin Infect Dis. 2018 Feb 14. pii: 4857181. doi: 10.1093.
    PubMed     Text format     Abstract available


  178. IZURIETA HS, Chillarige Y, Kelman JA, Forshee R, et al
    Statin use and risks of influenza-related outcomes among older adults receiving standard-dose or high-dose influenza vaccines through Medicare during 2010-2015.
    Clin Infect Dis. 2018 Feb 9. pii: 4846330. doi: 10.1093.
    PubMed     Text format     Abstract available


  179. SUZUKI M, Saito N
    Influenza vaccine effectiveness and age.
    Clin Infect Dis. 2018 Feb 7. pii: 4841718. doi: 10.1093.
    PubMed     Text format    


    January 2018
  180. VOYSEY M, Pollard AJ
    Sero-efficacy of Vi-polysaccharide tetanus-toxoid typhoid conjugate vaccine (Typbar-TCV).
    Clin Infect Dis. 2018 Jan 17. pii: 4815743. doi: 10.1093/cid/cix1145.
    PubMed     Text format     Abstract available


  181. BURGNER DP, Miller JE, Strunk T, Nassar N, et al
    Growth Parameters, Effect Measure Modification and the Association Between Vaccination and Early Childhood Hospitalization With Non-targeted Infections.
    Clin Infect Dis. 2018;66:318-319.
    PubMed     Text format    


  182. VAN DEURSEN AMM, van Houten MA, Webber C, Patton M, et al
    The impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study.
    Clin Infect Dis. 2018 Jan 6. pii: 4792029. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  183. SIMMONS G, Stone M, Busch MP
    Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus Vaccination and Zika Virus Epidemics.
    Clin Infect Dis. 2017 Dec 30. pii: 4760439. doi: 10.1093.
    PubMed     Text format    


  184. PLENNEVAUX E, Moureau A, Arredondo-Garcia JL, Villar L, et al
    Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials.
    Clin Infect Dis. 2017 Dec 30. pii: 4782289. doi: 10.1093.
    PubMed     Text format     Abstract available


  185. CHONG PP, Handler L, Weber DJ
    A Systematic Review of Safety and Immunogenicity of Influenza Vaccination Strategies in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2017 Dec 14. pii: 4743238. doi: 10.1093/cid/cix1081.
    PubMed     Text format     Abstract available


  186. NATORI Y, Shiotsuka M, Slomovic J, Hoschler K, et al
    A Double Blind Randomized Trial of High Dose vs. Standard Dose Influenza Vaccine in Adult Solid Organ Transplant Recipients.
    Clin Infect Dis. 2017 Dec 14. pii: 4743251. doi: 10.1093/cid/cix1082.
    PubMed     Text format     Abstract available


    November 2017
  187. LOPEZ AL, Deen J, Azman AS, Luquero FJ, et al
    Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and meta-analysis.
    Clin Infect Dis. 2017 Nov 21. pii: 4645296. doi: 10.1093/cid/cix1039.
    PubMed     Text format     Abstract available


  188. FISKER AB, Nebie E, Schoeps A, Martins C, et al
    A two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels.
    Clin Infect Dis. 2017 Nov 21. pii: 4645294. doi: 10.1093/cid/cix1033.
    PubMed     Text format     Abstract available


  189. YE S, Whiley DM, Ware RS, Kirkwood CD, et al
    Multivalent rotavirus vaccine and wild-type rotavirus strain shedding in Australian infants: a birth cohort study.
    Clin Infect Dis. 2017 Nov 15. doi: 10.1093/cid/cix1022.
    PubMed     Text format     Abstract available


  190. STEIN Y, Mandelboim M, Sefty H, Pando R, et al
    Seasonal influenza vaccine effectiveness in preventing laboratory-confirmed influenza in primary care in Israel 2016-2017 season: insights into novel age-specific analysis.
    Clin Infect Dis. 2017 Nov 14. doi: 10.1093/cid/cix1013.
    PubMed     Text format     Abstract available


  191. VEIT O, Domingo C, Niedrig M, Staehelin C, et al
    Long-term immune response to yellow fever vaccination in HIV-infected individuals depends on HIV-RNA suppression status: Implications for vaccination schedule.
    Clin Infect Dis. 2017 Nov 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  192. LAWN JE, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, et al
    Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates?
    Clin Infect Dis. 2017;65.
    PubMed     Text format     Abstract available


    October 2017
  193. FATHIMA P, Blyth CC, Lehmann D, Lim FJ, et al
    The impact of pneumococcal vaccination on bacterial and viral pneumonia in Western Australian children: record linkage cohort study of 469,589 births (1996-2012).
    Clin Infect Dis. 2017 Oct 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  194. TAM YH, Valkenburg SA, Perera RAPM, Wong JHF, et al
    Immune responses to twice-annual influenza vaccination in older adults in Hong Kong.
    Clin Infect Dis. 2017 Oct 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  195. POEHLING KA, Caspard H, Peters TR, Belongia EA, et al
    2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  196. ORTIZ JR
    The challenge of vaccine policy-making with imperfect data.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format    


  197. KJAER SK, Nygard M, Dillner J, Brooke Marshall J, et al
    A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries.
    Clin Infect Dis. 2017 Oct 1. doi: 10.1093.
    PubMed     Text format     Abstract available


  198. EBERHARDSON M, Hall S, Papp KA, Sterling TM, et al
    Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Clin Infect Dis. 2017;65:1174-1182.
    PubMed     Text format     Abstract available


  199. OLIGBU G, Collins S, Andrews N, Sheppard CL, et al
    Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.
    Clin Infect Dis. 2017;65:1191-1198.
    PubMed     Text format     Abstract available


    September 2017
  200. SKOFF TH, Blain AE, Watt J, Scherzinger K, et al
    Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.
    Clin Infect Dis. 2017 Sep 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  201. LUCA DL, Kwong JC, Chu A, Sander B, et al
    Impact of Pneumococcal Vaccination on Pneumonia Hospitalizations and Related Costs in Ontario: A Population-Based Ecological Study.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  202. NEMES E, Hesseling AC, Tameris M, Mauff K, et al
    Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  203. MADHI SA, Koen A, Cutland CL, Jose L, et al
    Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.
    Clin Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  204. ARCIUOLO RJ, Jablonski RR, Zucker JR, Rosen JB, et al
    Effectiveness of Measles Vaccination and Immune Globulin Post-Exposure Prophylaxis in an Outbreak Setting-New York City, 2013.
    Clin Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  205. SCHROEDER MR, Chancey ST, Thomas S, Kuo WH, et al
    A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance
    Clin Infect Dis. 2017;65:990-998.
    PubMed     Text format     Abstract available


  206. KIM L, Rha B, Abramson JS, Anderson LJ, et al
    Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines.
    Clin Infect Dis. 2017;65:1020-1025.
    PubMed     Text format     Abstract available


  207. PIROTH L, Launay O, Miailhes P, Carrat F, et al
    Isolated anti-HBc serological profile: has the time come to vaccinate?
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format    


  208. MCNAMARA LA, Skoff T, Faulkner A, Miller L, et al
    Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination-United States, 2010-2012.
    Clin Infect Dis. 2017;65:811-818.
    PubMed     Text format     Abstract available


  209. VAN DEURSEN AMM, van Houten MA, Webber C, Patton M, et al
    Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
    Clin Infect Dis. 2017;65:787-795.
    PubMed     Text format     Abstract available


  210. PILLSBURY AJ, Quinn HE, Evans TD, McIntyre PB, et al
    Population-Level Herd Protection of Males From a Female Human Papillomavirus Vaccination Program: Evidence from Australian Serosurveillance.
    Clin Infect Dis. 2017;65:827-832.
    PubMed     Text format     Abstract available


    August 2017
  211. YANG Y, Meng Y, Halloran ME, Longini IM Jr, et al
    Dependency of Vaccine Efficacy on Pre-Exposure and Age: A Closer Look at a Tetravalent Dengue Vaccine.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  212. LEE YJ, Huang YT, Kim SJ, Kerpelev M, et al
    Trends in invasive pneumococcal disease (IPD) in cancer patients after the introduction of 7-valent pneumococcal conjugate vaccine (PCV7): A 20-year longitudinal study at a major urban cancer center.
    Clin Infect Dis. 2017 Aug 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  213. SHAH M, Quinlisk P, Weigel A, Riley J, et al
    Mumps outbreak in a highly vaccinated university-affiliated setting before and after a measles-mumps-rubella (MMR) vaccination campaign-Iowa, July 2015-May 2016.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  214. HEATH G, Depledge DP, Brown JR, Hale AD, et al
    Acute Retinal Necrosis caused by the zoster vaccine virus.
    Clin Infect Dis. 2017 Aug 2. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  215. LEWNARD JA, Givon-Lavi N, Weinberger DM, Lipsitch M, et al
    Pan-serotype reduction in progression of Streptococcus pneumoniae to otitis media after rollout of pneumococcal conjugate vaccines.
    Clin Infect Dis. 2017 Jul 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  216. WARREN JL, Shioda K, Kurum E, Schuck-Paim C, et al
    Impact of Pneumococcal Conjugate Vaccines on Pneumonia Hospitalizations in High- and Low-Income Subpopulations in Brazil.
    Clin Infect Dis. 2017 Jul 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  217. PETRIE JG, Malosh RE, Cheng CK, Ohmit SE, et al
    The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  218. ZUCMAN D, Farfour E, Mazaux L, Hillaire S, et al
    How to face the outbreak of viral hepatitis A in men-who-have-sex-with-men in France without vaccines?
    Clin Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format    


  219. DE WALS P, Deceuninck G, Lefebvre B, Tsang R, et al
    Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.
    Clin Infect Dis. 2017;64:1263-1267.
    PubMed     Text format     Abstract available


    December 2016
  220. LARSON HJ
    Japanese media and the HPV vaccine saga.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  221. GILL CJ, Mwananyanda L, MacLeod W, Kwenda G, et al
    Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


    June 2016
  222. TRAN TT
    Hepatitis B in Pregnancy.
    Clin Infect Dis. 2016;62 Suppl 4:S314-7.
    PubMed     Text format     Abstract available


  223. SHANKAR H, Blanas D, Bichoupan K, Ndiaye D, et al
    A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants.
    Clin Infect Dis. 2016;62 Suppl 4:S289-97.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: